These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 15231670)
1. Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis. Eckert LB; Repasky GA; Ulkü AS; McFall A; Zhou H; Sartor CI; Der CJ Cancer Res; 2004 Jul; 64(13):4585-92. PubMed ID: 15231670 [TBL] [Abstract][Full Text] [Related]
2. K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1. Sheng H; Shao J; Dubois RN Cancer Res; 2001 Mar; 61(6):2670-5. PubMed ID: 11289146 [TBL] [Abstract][Full Text] [Related]
3. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546 [TBL] [Abstract][Full Text] [Related]
4. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Kim MS; Lee EJ; Kim HR; Moon A Cancer Res; 2003 Sep; 63(17):5454-61. PubMed ID: 14500381 [TBL] [Abstract][Full Text] [Related]
5. Tyrosine kinase-dependent, phosphatidylinositol 3'-kinase, and mitogen-activated protein kinase-independent signaling pathways prevent lung adenocarcinoma cells from anoikis. Wei L; Yang Y; Yu Q Cancer Res; 2001 Mar; 61(6):2439-44. PubMed ID: 11289112 [TBL] [Abstract][Full Text] [Related]
6. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways. Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018 [TBL] [Abstract][Full Text] [Related]
7. The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner. Chakravarti A; Chakladar A; Delaney MA; Latham DE; Loeffler JS Cancer Res; 2002 Aug; 62(15):4307-15. PubMed ID: 12154034 [TBL] [Abstract][Full Text] [Related]
8. Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells. Normanno N; De Luca A; Bianco C; Maiello MR; Carriero MV; Rehman A; Wechselberger C; Arra C; Strizzi L; Sanicola M; Salomon DS J Cell Physiol; 2004 Jan; 198(1):31-9. PubMed ID: 14584041 [TBL] [Abstract][Full Text] [Related]
9. p21ras initiates Rac-1 but not phosphatidyl inositol 3 kinase/PKB, mediated signaling pathways in T lymphocytes. Genot E; Reif K; Beach S; Kramer I; Cantrell D Oncogene; 1998 Oct; 17(13):1731-8. PubMed ID: 9796702 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity. deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641 [TBL] [Abstract][Full Text] [Related]
11. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line. Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997 [TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling. Ravid D; Maor S; Werner H; Liscovitch M Oncogene; 2005 Feb; 24(8):1338-47. PubMed ID: 15592498 [TBL] [Abstract][Full Text] [Related]
13. COX-2 inhibits anoikis by activation of the PI-3K/Akt pathway in human bladder cancer cells. Choi EM; Kwak SJ; Kim YM; Ha KS; Kim JI; Lee SW; Han JA Exp Mol Med; 2005 Jun; 37(3):199-203. PubMed ID: 16000874 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer. Kurokawa H; Arteaga CL Clin Cancer Res; 2001 Dec; 7(12 Suppl):4436s-4442s; discussion 4411s-4412s. PubMed ID: 11916237 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation. Menendez JA; Mehmi I; Verma VA; Teng PK; Lupu R Mol Carcinog; 2004 Nov; 41(3):164-78. PubMed ID: 15390078 [TBL] [Abstract][Full Text] [Related]
16. Opposite effects of Ha-Ras and Ki-Ras on radiation-induced apoptosis via differential activation of PI3K/Akt and Rac/p38 mitogen-activated protein kinase signaling pathways. Choi JA; Park MT; Kang CM; Um HD; Bae S; Lee KH; Kim TH; Kim JH; Cho CK; Lee YS; Chung HY; Lee SJ Oncogene; 2004 Jan; 23(1):9-20. PubMed ID: 14712206 [TBL] [Abstract][Full Text] [Related]
17. Human intestinal epithelial crypt cell survival and death: Complex modulations of Bcl-2 homologs by Fak, PI3-K/Akt-1, MEK/Erk, and p38 signaling pathways. Harnois C; Demers MJ; Bouchard V; Vallée K; Gagné D; Fujita N; Tsuruo T; Vézina A; Beaulieu JF; Côté A; Vachon PH J Cell Physiol; 2004 Feb; 198(2):209-22. PubMed ID: 14603523 [TBL] [Abstract][Full Text] [Related]
19. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways. Bouchard V; Demers MJ; Thibodeau S; Laquerre V; Fujita N; Tsuruo T; Beaulieu JF; Gauthier R; Vézina A; Villeneuve L; Vachon PH J Cell Physiol; 2007 Sep; 212(3):717-28. PubMed ID: 17443665 [TBL] [Abstract][Full Text] [Related]
20. Activation of the Ral and phosphatidylinositol 3' kinase signaling pathways by the ras-related protein TC21. Rosário M; Paterson HF; Marshall CJ Mol Cell Biol; 2001 Jun; 21(11):3750-62. PubMed ID: 11340168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]